Literature DB >> 21307184

Human cytomegalovirus pUS27 G protein-coupled receptor homologue is required for efficient spread by the extracellular route but not for direct cell-to-cell spread.

Christine M O'Connor1, Thomas Shenk.   

Abstract

Human cytomegalovirus (HCMV) encodes multiple G protein-coupled receptor (GPCR) homologues, including pUS27, pUS28, pUL33, and pUL78. To explore the function of pUS27, we constructed pUS27-deficient derivates of two clinical isolates of HCMV. BFX-GFPstopUS27 is a FIX variant with a single base pair change in the US27 open reading frame, generating a stop codon that ablates accumulation of the GPCR homologue, and TB40/E-mCherrydlUS27 lacks the entire US27 coding region. BFX-GFPstopUS27 generated 10-fold less extracellular progeny in fibroblasts, and TB40/E-mCherrydlUS27 exhibited a similar defect in endothelial cells. The pUS27-deficient FIX derivative produced normal quantities of viral DNA and viral proteins tested, and a late virion protein was appropriately localized to the cytoplasmic assembly zone. After infection at a low multiplicity with wild-type FIX virus, neutralizing antibody reduced the accumulation of intracellular viral DNA and intracellular virions, as would be expected if the virus is limited to direct cell-to-cell spread by neutralization of extracellular virus. In contrast, the antibody had little effect on the spread of the BFX-GFPstopUS27 virus. Further, after infection at a low multiplicity, the pUS27-deficient TB40/E virus exhibited a growth defect in endothelial cells, where the clinical isolate normally generates extracellular virus, but the TB40/E derivative exhibited little defect in epithelial cells, where the wild-type virus does not produce extracellular virus. Thus, mutants lacking pUS27 rely primarily on direct cell-to-cell spread, and we conclude that the viral GCPR homologue acts at a late stage of the HCMV replication cycle to support spread of virus by the extracellular route.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307184      PMCID: PMC3126124          DOI: 10.1128/JVI.02442-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Localization of HCMV UL33 and US27 in endocytic compartments and viral membranes.

Authors:  Alberto Fraile-Ramos; Annegret Pelchen-Matthews; Thomas N Kledal; Helena Browne; Thue W Schwartz; Mark Marsh
Journal:  Traffic       Date:  2002-03       Impact factor: 6.215

2.  A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA.

Authors:  E C Lee; D Yu; J Martinez de Velasco; L Tessarollo; D A Swing; D L Court; N A Jenkins; N G Copeland
Journal:  Genomics       Date:  2001-04-01       Impact factor: 5.736

Review 3.  Towards a systems biology approach of-G protein-coupled receptor signalling: challenges and expectations.

Authors:  Domitille Heitzler; Pascale Crépieux; Anne Poupon; Frédérique Clément; François Fages; Eric Reiter
Journal:  C R Biol       Date:  2009-10-14       Impact factor: 1.583

4.  Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs.

Authors:  E P Browne; B Wing; D Coleman; T Shenk
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration.

Authors:  D N Streblow; C Soderberg-Naucler; J Vieira; P Smith; E Wakabayashi; F Ruchti; K Mattison; Y Altschuler; J A Nelson
Journal:  Cell       Date:  1999-11-24       Impact factor: 41.582

6.  Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28.

Authors:  P Casarosa; R A Bakker; D Verzijl; M Navis; H Timmerman; R Leurs; M J Smit
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

7.  Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids.

Authors:  Maria C Silva; Qian-Chun Yu; Lynn Enquist; Thomas Shenk
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities.

Authors:  Maria Waldhoer; Thomas N Kledal; Helen Farrell; Thue W Schwartz
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome.

Authors:  Susan M Varnum; Daniel N Streblow; Matthew E Monroe; Patricia Smith; Kenneth J Auberry; Ljiljana Pasa-Tolic; Dai Wang; David G Camp; Karin Rodland; Steven Wiley; William Britt; Thomas Shenk; Richard D Smith; Jay A Nelson
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics.

Authors:  Gabriele Hahn; Hanna Khan; Fausto Baldanti; Ulrich H Koszinowski; M Grazia Revello; Giuseppe Gerna
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more
  61 in total

1.  Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees.

Authors:  Ravit Arav-Boger; Sallie R Permar; Cody S Nelson; Diana Vera Cruz; Melody Su; Guanhua Xie; Nathan Vandergrift; Robert F Pass; Michael Forman; Marie Diener-West; Katia Koelle
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

2.  BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.

Authors:  Song Hee Lee; Robert F Kalejta; Julie Kerry; Oliver John Semmes; Christine M O'Connor; Zia Khan; Benjamin A Garcia; Thomas Shenk; Eain Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

3.  Development of a Primary Human Cell Model for the Study of Human Cytomegalovirus Replication and Spread within Salivary Epithelium.

Authors:  Kristen M Morrison; Matthew J Beucler; Emily O Campbell; Margaret A White; Rachel E Boody; Keith C Wilson; William E Miller
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

4.  Quantitative proteomic discovery of dynamic epigenome changes that control human cytomegalovirus (HCMV) infection.

Authors:  Christine M O'Connor; Peter A DiMaggio; Thomas Shenk; Benjamin A Garcia
Journal:  Mol Cell Proteomics       Date:  2014-07-01       Impact factor: 5.911

5.  Methods for Studying the Function of Cytomegalovirus GPCRs.

Authors:  Christine M O'Connor; William E Miller
Journal:  Methods Mol Biol       Date:  2021

6.  Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.

Authors:  Xiaohong Cui; Daniel C Freed; Dai Wang; Ping Qiu; Fengsheng Li; Tong-Ming Fu; Lawrence M Kauvar; Michael A McVoy
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

7.  Evolution of the ability to modulate host chemokine networks via gene duplication in human cytomegalovirus (HCMV).

Authors:  Jessica A Scarborough; John R Paul; Juliet V Spencer
Journal:  Infect Genet Evol       Date:  2017-03-14       Impact factor: 3.342

8.  Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1-Exposed Infants.

Authors:  Kristy M Bialas; Daniel Westreich; Eduardo Cisneros de la Rosa; Cody S Nelson; Lawrence M Kauvar; Tong-Ming Fu; Sallie R Permar
Journal:  J Infect Dis       Date:  2016-10-20       Impact factor: 5.226

Review 9.  Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.

Authors:  Silvia Montaner; Irina Kufareva; Ruben Abagyan; J Silvio Gutkind
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-10-22       Impact factor: 13.820

10.  The US27 gene product of human cytomegalovirus enhances signaling of host chemokine receptor CXCR4.

Authors:  Kathleen L Arnolds; Angela P Lares; Juliet V Spencer
Journal:  Virology       Date:  2013-03-13       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.